Resource Library
Toolkits, guides, and other resources vetted by experts in overdose prevention.
Filter by category and tags, or search by keyword (ex. COVID-19, harm reduction).
Report: Practicing Harm Reduction in a Climate of Disasters (2021)
This report analyzes research on harm reduction practices in the context of disasters such as climate-related and systems-disrupting disasters.
CHLP Judy Moore Remarks
Dr. Judy Moore offers advice on how we should proceed as public health leaders in the fight against COVID-19 and other health crises.
With crisis comes opportunity: Unanticipated benefits resulting from pivots to take-home naloxone (THN) programs during the COVID-19 pandemic
This commentary describes how four rural and/or Appalachian communities quickly pivoted their existing THN (take home naloxone) programs to respond to community need.
4 Big Ideas – Applying learnings from COVID to the U.S. approach to the overdose crisis
This presentation compares our response to COVID-19 with our response to the overdose epidemic. It explains the need for innovation and progressive thinking to create change with how we approach substance use disorder as both a medical and community-based crisis.
COVID-19 Resources for People Who Use Drugs and Other Vulnerable Communities
This toolkit provides informative fact sheets, tips, and guidance for people who use drugs, engage in sex work, those who are unhoused, and the stakeholders who work with these communities.
Pharmacy Access to Sterile Injection Supplies for People Who Inject Drugs
There can be a lot of pushback in communities when it comes to syringe services. This article about how pharmacies can expand over-the-counter sterile injection supplies to prevent the spread of infection, especially during COVID-19.
National Roadmap on State-Level Efforts to End the Nation’s Drug Overdose Epidemic
This document was originally released in 2019 as a guide to help policymakers end the opioid epidemic. This document has now been expanded to include best practices and action items regarding COVID-19 and racial inequities.
Colliding Crises: Using Persuasive Narratives to Tell the Story of Overdose Prevention
This webinar introduces you to powerful communication strategies to help focus attention on how COVID-19 is affecting your community and discusses how to use persuasive narratives to break through the clutter.
Change Management Strategies: Adapting Your Coalition in the Era of COVID-19
This session offers insights into how to think about the current moment as a way forward for your coalition. We offer strategies for managing change, and generate discussion on how to adapt your coalition in light of this shifting environment.
Harm Reduction and COVID-19: How to adapt your community strategies
This webinar features Savannah O’Neill from the Harm Reduction Coalition who addresses the impact of COVID-19 on people who use drugs, how to adapt your local programs, and available resources.
Trauma Informed Communities: How trauma impacts ourselves, our communities and our response to COVID-19
This workshop discusses the neurobiology of trauma, community trauma and inherent community resilience, how COVID-19 is impacting our levels of toxic stress, and how we can take tangible steps to heal ourselves individually and transform our organizations into trauma-responsive agencies.
Medications for Addiction Treatment (MAT) Management During COVID-19: 6 Takeaways
Guidance from the federal and state government about the delivery of and payment for remote services (e.g., telehealth), links to virtual recovery supports for patients with substance use disorder, approaches to team care and self-care, and links to key content from other programs.
DEA and Telehealth
This site gives resources and updates on telehealth policies, during COVID-19.
Resources for drug use and COVID-19 risk reduction
Guidance documents, government advisories, and tools for people who use drugs and stakeholders likely to engage with people who use drugs
Practicing Harm Reduction in the COVID-19 Outbreak
Guidance for syringe services/harm reduction providers and safer drug use in the COVID-19 outbreak.